Acura Pharmaceuticals Inc (NASDAQ:ACUR)

Data as of Jan 23
 -0.03 / -5.17%
Today’s Change
Today|||52-Week Range

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year




Operating ActivitiesNet Income / Starting Line-12.7M10.4M-9.7M-13.9M
Total Other Cash Flow6.8M2.5M1.7M1.5M
Funds From Operations-5.8M13.0M-7.8M-12.3M
Funds From/For Other Operating Expenses668.0K670.0K-758.0K1.4M
Net Cash Flow - Operating Activities-6.5M12.3M-7.0M-13.7M
InvestingNet Cash Flow Investing-41.0K-131.0K-20.1M6.3M
FinancingShort Term Borrowings----------
Long Term Borrowings----------
Long Term Debt Reduction----------
Net Proceeds Stock Sale----------
Common Preferred Redeemed----------
Common Dividends----------
Cash Dividends Paid - Total0.
Other Sources - Financing----------
Other Uses - Financing----------
Net Cash Flow - Financing392.0K-541.0K-1.0M12.3M
Exchange RateEffect of Exchange Rate on Cash----0.000.00--
Net Change In Cash-6.1M11.6M-28.2M4.9M

Most stock quote data provided by BATS. Market indices are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer.

Morningstar: © 2015 Morningstar, Inc. All Rights Reserved.

Factset: FactSet Research Systems Inc. 2015. All rights reserved.

Chicago Mercantile Association: Certain market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved.

Dow Jones: The Dow Jones branded indices are proprietary to and are calculated, distributed and marketed by DJI Opco, a subsidiary of S&P Dow Jones Indices LLC and have been licensed for use to S&P Opco, LLC and CNN. Standard & Poor's and S&P are registered trademarks of Standard & Poor’s Financial Services LLC and Dow Jones is a registered trademark of Dow Jones Trademark Holdings LLC. All content of the Dow Jones branded indices © S&P Dow Jones Indices LLC 2015 and/or its affiliates.